Skip to main navigation Skip to search Skip to main content

PTHrP-Induced Refractory Malignant Hypercalcemia in a Patient With Chronic Lymphocytic Leukemia Responding to Denosumab

  • Ameen A. Salahudeen
  • , Arjun Gupta
  • , Jeremy C. Jones
  • , Robert W. Cowan
  • , Madhuri Vusirikala
  • , Chi Kwong
  • , Harris V.K. Naina

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Article number619
Pages (from-to)e137-e140
JournalClinical Lymphoma, Myeloma and Leukemia
Volume15
Issue number9
DOIs
StatePublished - Sep 1 2015
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CLL
  • Denosumab
  • Humoral hypercalcemia
  • Hypercalcemia of malignancy
  • PTHrP
  • Parathyroid hormone-related protein

Cite this